Investors & Media

홈Investors & MediaNews release

News release

게시물 상세
Investors VasThera to Attend Bio Japan 2023
VasThera(bd@vasthera.com)Date : 2023-10-20View : 995

 

VasThera to Attend Bio Japan 2023

 


 

 

VasThera Co., Ltd. (VasThera) participated in the Bio Japan 2023 conference in Yokohama, Japan in October.

 

Held for three days from October 11th, Bio Japan is the Asia's largest partnering conference for the pharmaceutical and biotechnology sectors, which began in 1986 and 

attracted more than 1500 global biotech companies this year. 

 

Dr. Sang Won Kang, CEO of VasThera, participated in partnering meetings to promote VasThera's pipeline of innovative new drugs to pharmaceutical companies from 

Japan and other countries, as well as business collaborations. VasThera strengthened collaborative relationships with companies with whom already have established 

existing networks and held active business discussions with new companies.

 

VasThera will continue to focus on R&D for innovative drug development and build strategic partnerships with global pharmaceutical and biotech companies.


Prev VasThera to Attend BIO-Europe 2023
Next VasThera’s Dr. Sang Won Kang to Present at the 2022 BIO International Convention
TOPTOP
검색 닫기